FindTrial
Sign In

Retrospective analysis of perioperative clinical outcomes of patients with novel coronavirus Omikron virus infection undergoing elective surgery

Retrospective analysis of perioperative clinical outcomes of patients with novel coronavirus Omikron virus infection undergoing elective surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300071913
Enrollment
Unknown
Registered
2023-05-29
Start date
2023-05-30
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus Omikron virus

Interventions

COVID-19 nucleic acid positive group:None
COVID-19 nucleic acid negative group:None

Sponsors

Army Medical Center of PLA
Lead Sponsor

Eligibility

Sex/Gender
All
Age
10 Years to 130 Years

Inclusion criteria

Inclusion criteria: All patients who underwent surgery at our hospital from October 2022 to February 2023.

Exclusion criteria

Exclusion criteria: Patients refuse to conduct nucleic acid testing, and there is no record of COVID-19 testing in the medical system.

Design outcomes

Primary

MeasureTime frame
kidney function;inflammatory Factors ;routine urine test;liver function;Blood routine;six items of blood coagulation;TEG thromboelastogram;Nucleic acid detection of novel coronavirus;glycosylated hemoglobin;—

Countries

China

Contacts

Public ContactQingxiang Mao

Army Medical Center of PLA

maomaosmmu@126.com+86 172 6569 5832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026